DRKS00034286尚未招募不适用
Quality assurance initiative for the treatment of breast cancer in Germany 2024
KEM Evangelische Kliniken Essen Mitte0 个研究点目标入组 3,000 人开始时间: 2024年5月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one(—)
- 性别
- All
入选标准
- •EBC: HER2+, TNBC or HER2-/HR+ UICC II or higher; surgery between April and August 2024
- •MBC: drug-based tumor therapy in current line; start of treatment line no more than 6 months in ago (April 2024 or later)
排除标准
- •Patients who are not receiving any drug-based tumor therapy in current primary therapy or in the current MBC treatment line;
- •Patients who are treated exclusively with osteoprotectants
研究者
相似试验
已完成
不适用
Quality Assurance Initiative on the Therapy of Bladder Cancer 2023C67Malignant neoplasm of bladderDRKS00032582Arbeitsgemeinschaft Urologische Onkologie1,639
尚未招募
不适用
Quality assurance initiative for systemic treatment in metastatic colorectal cancerC18C19C20Malignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of rectumDRKS00033377Charite Berlin - Medizinischen Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie (CCM)2,100
尚未招募
3 期
Study to implement nutritional diet to improve the nutritional status among patients admitted in main ICU of Nehru Hospital, PGIMER, chandigarh (2021-2023)CTRI/2022/05/042849Main ICU Nehru Hospital PGIMER
招募中
不适用
Quality Assurance of Invasive Measures for Treatment of Parkinson Patients in Clinical Routine in GermanyOPS 5-014.9OPS 5-028.9G20Parkinson diseaseDRKS00011709Institut für Klinische Epidemiologie und Biometrie (IKE-B) Universität Würzburg1,600
已完成
Unknown
Quality improvement study for the prevention of post caesarean nosocomial infection in a tertiary care centreCTRI/2023/08/056515Post Graduate Institute of Medical Education and Research Chandigarh253
